P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases. 2010

Takato Takenouchi, and Kazunari Sekiyama, and Akio Sekigawa, and Masayo Fujita, and Masaaki Waragai, and Shuei Sugama, and Yoshifumi Iwamaru, and Hiroshi Kitani, and Makoto Hashimoto
Laboratory for Chemistry and Metabolism, Tokyo Metropolitan Institute for Neuroscience, Fuchu, Tokyo 183-8526, Japan.

A recent study suggested that neuroinflammation plays a major role in the pathogenesis of a number of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Although the precise mechanism is obscure, dysregulation of the signaling transduction pathway in microglia may enhance inflammation, leading to synaptic dysfunction and ultimately to neuronal cell death. The expression and function of the P2X7 receptor (P2X7R), an ATP-gated ion channel abundantly expressed in microglia in the brain, is significantly up-regulated in the postmortem brain of Alzheimer's disease patients and various neurodegenerative disease animal models. This supports the role of the P2X7R pathway in the progression of neurodegeneration. Blocking P2X7R using brilliant blue G, a P2X7R antagonist that can cross the blood-brain barrier, has been shown to result in the amelioration of neuropathology in various animal models. Taken together, these results raise the possibility that the P2X7R signaling pathway could be a therapeutic target for treating various neurodegenerative diseases.

UI MeSH Term Description Entries
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004660 Encephalitis Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition. Inflammation, Brain,Rasmussen Syndrome,Brain Inflammation,Encephalitis, Rasmussen,Rasmussen Encephalitis,Rasmussen's Syndrome,Brain Inflammations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001253 Astrocytes A class of large neuroglial (macroglial) cells in the central nervous system - the largest and most numerous neuroglial cells in the brain and spinal cord. Astrocytes (from "star" cells) are irregularly shaped with many long processes, including those with "end feet" which form the glial (limiting) membrane and directly and indirectly contribute to the BLOOD-BRAIN BARRIER. They regulate the extracellular ionic and chemical environment, and "reactive astrocytes" (along with MICROGLIA) respond to injury. Astroglia,Astroglia Cells,Astroglial Cells,Astrocyte,Astroglia Cell,Astroglial Cell,Astroglias,Cell, Astroglia,Cell, Astroglial
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation
D017628 Microglia The third type of glial cell, along with astrocytes and oligodendrocytes (which together form the macroglia). Microglia vary in appearance depending on developmental stage, functional state, and anatomical location; subtype terms include ramified, perivascular, ameboid, resting, and activated. Microglia clearly are capable of phagocytosis and play an important role in a wide spectrum of neuropathologies. They have also been suggested to act in several other roles including in secretion (e.g., of cytokines and neural growth factors), in immunological processing (e.g., antigen presentation), and in central nervous system development and remodeling. Microglial Cell,Cell, Microglial,Microglial Cells,Microglias

Related Publications

Takato Takenouchi, and Kazunari Sekiyama, and Akio Sekigawa, and Masayo Fujita, and Masaaki Waragai, and Shuei Sugama, and Yoshifumi Iwamaru, and Hiroshi Kitani, and Makoto Hashimoto
January 2016, Advances in protein chemistry and structural biology,
Takato Takenouchi, and Kazunari Sekiyama, and Akio Sekigawa, and Masayo Fujita, and Masaaki Waragai, and Shuei Sugama, and Yoshifumi Iwamaru, and Hiroshi Kitani, and Makoto Hashimoto
August 2019, Autoimmunity reviews,
Takato Takenouchi, and Kazunari Sekiyama, and Akio Sekigawa, and Masayo Fujita, and Masaaki Waragai, and Shuei Sugama, and Yoshifumi Iwamaru, and Hiroshi Kitani, and Makoto Hashimoto
September 2024, Translational neurodegeneration,
Takato Takenouchi, and Kazunari Sekiyama, and Akio Sekigawa, and Masayo Fujita, and Masaaki Waragai, and Shuei Sugama, and Yoshifumi Iwamaru, and Hiroshi Kitani, and Makoto Hashimoto
May 2008, Expert opinion on therapeutic targets,
Takato Takenouchi, and Kazunari Sekiyama, and Akio Sekigawa, and Masayo Fujita, and Masaaki Waragai, and Shuei Sugama, and Yoshifumi Iwamaru, and Hiroshi Kitani, and Makoto Hashimoto
October 2025, Molecular and cellular biochemistry,
Takato Takenouchi, and Kazunari Sekiyama, and Akio Sekigawa, and Masayo Fujita, and Masaaki Waragai, and Shuei Sugama, and Yoshifumi Iwamaru, and Hiroshi Kitani, and Makoto Hashimoto
April 2014, Neuroscience letters,
Takato Takenouchi, and Kazunari Sekiyama, and Akio Sekigawa, and Masayo Fujita, and Masaaki Waragai, and Shuei Sugama, and Yoshifumi Iwamaru, and Hiroshi Kitani, and Makoto Hashimoto
January 2011, Journal of Alzheimer's disease : JAD,
Takato Takenouchi, and Kazunari Sekiyama, and Akio Sekigawa, and Masayo Fujita, and Masaaki Waragai, and Shuei Sugama, and Yoshifumi Iwamaru, and Hiroshi Kitani, and Makoto Hashimoto
November 2020, Medicinal research reviews,
Takato Takenouchi, and Kazunari Sekiyama, and Akio Sekigawa, and Masayo Fujita, and Masaaki Waragai, and Shuei Sugama, and Yoshifumi Iwamaru, and Hiroshi Kitani, and Makoto Hashimoto
January 2020, Frontiers in molecular neuroscience,
Takato Takenouchi, and Kazunari Sekiyama, and Akio Sekigawa, and Masayo Fujita, and Masaaki Waragai, and Shuei Sugama, and Yoshifumi Iwamaru, and Hiroshi Kitani, and Makoto Hashimoto
January 2017, Current Alzheimer research,
Copied contents to your clipboard!